Clinical Trial Update: HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD) [Phase 3]

View source ↗

Summary

Phase 3 trial update for peginterferon alfa-2a (Pegasys) in chronic hepatitis C patients, including those with end-stage renal disease, with results posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2016-10-31